Wuxi AstraZeneca CICC Venture Capital Partnership

Other · Wuxi, Jiangsu

Wuxi AstraZeneca CICC Venture Capital Partnership is a money management firm based in Wuxi, China. 8 portfolio companies are on record.

AUM
—
Portfolio companies
8
Recorded deals
—
Last investment
—

Wuxi AstraZeneca CICC Venture Capital Partnership key facts

  • Wuxi AstraZeneca CICC Venture Capital Partnership is a other based in Wuxi, Jiangsu with 8 tracked portfolio companies.
  • Notable positions include Highlightll Pharma, YolTech Therapeutics, Newrite Medical.

About Wuxi AstraZeneca CICC Venture Capital Partnership

Wuxi AstraZeneca CICC Venture Capital Partnership is a money management firm based in Wuxi, China. Established in 2020, the firm offers investment activities using its own funds, venture capital and equity investments, investment management, and asset management services. The assets are managed by the executive management team.

Wuxi AstraZeneca CICC Venture Capital Partnership portfolio at a glance

8 portfolio companies are on record for Wuxi AstraZeneca CICC Venture Capital Partnership, including Highlightll Pharma, YolTech Therapeutics and Newrite Medical.

3 of the 8 carry a recorded valuation.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 8 recorded positions
  • ·Watchlist + alerts for Wuxi AstraZeneca CICC Venture Capital Partnership's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

8 companies · priced for members
CompanyValuationRole
Highlightll Pharma▮▮
YolTech Therapeutics▮▮
Newrite Medical▮▮
+ 5 more companies · all 8, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Frequently asked about Wuxi AstraZeneca CICC Venture Capital Partnership

What companies does Wuxi AstraZeneca CICC Venture Capital Partnership invest in?
Wuxi AstraZeneca CICC Venture Capital Partnership has 8 recorded portfolio companies, including Highlightll Pharma, YolTech Therapeutics, Newrite Medical.